Clinical Trials List
2020-10-16 - 2024-04-30
Phase II
Recruiting3
-
Trial Applicant
BAYER TAIWAN COMPANY LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Yi-Ping Hung Division of Hematology & Oncology
- San-Chi Chen Division of Hematology & Oncology
- Yun-Cheng Hsieh Division of Hematology & Oncology
- Chung-Pin Li Division of Hematology & Oncology
- Yi-Wei Chen Division of Hematology & Oncology
- Jiun-I Lai Division of Hematology & Oncology
- 陳盛裕 未分科
- Sheng-Yu Chen Division of Hematology & Oncology
- Shao-Jung Hsu Division of Hematology & Oncology
- Ming-Huang Chen Division of Hematology & Oncology
- Mu-Hsin Chang Division of Hematology & Oncology
- Yee Chao Division of Hematology & Oncology
- 許秉權 Division of Hematology & Oncology
- Muh-Hwa Yang Division of Hematology & Oncology
- Pei-Chang Lee Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ming-Hung Tsai Division of Hematology & Oncology
- Yu-Min Liao Division of Hematology & Oncology
- Chang-Fang Chiu Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
- Chen-Yuan Lin Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 高婉真 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
14 participants
-
Global
175 participants